Endoscopy 2006; 38(4): 404-407
DOI: 10.1055/s-2006-925054
Short Communication
© Georg Thieme Verlag KG Stuttgart · New York

Mitomycin C: An Alternative Conservative Treatment for Refractory Esophageal Stricture in Children?

S.  Uhlen1 , P.  Fayoux2 , F.  Vachin2 , D.  Guimber1 , F.  Gottrand1 , D.  Turck1 , L.  Michaud1
  • 1Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University Hospital and Faculty of Medcine, Lille, France
  • 2Department of Otolaryngology, Head and Neck Surgery, University Hospital and Faculty of Medicine, Lille, France
Further Information

Publication History

Submitted 24 August 2005

Accepted after revision 27 October 2005

Publication Date:
03 February 2006 (online)

Preview

Background and Study Aims: Mitomycin C is an antiproliferative agent that has been used successfully as an adjunct treatment in ophthalmological procedures, in the management of laryngeal and tracheal stenosis, and more recently to prevent the recurrence of caustic esophageal strictures in children. The aim of this study was to assess the efficacy and safety of local application of mitomycin C to refractory esophageal strictures in children.
Patients and Methods: We performed a preliminary prospective study of local application of mitomycin C in four children, aged between 1 year and 6 years, who had refractory esophageal strictures. Two of the children presented with strictures caused by caustic ingestion and the other two children had anastomotic strictures following surgical repair of congenital esophageal atresia. The patients had required between four and ten esophageal dilations over a 5 - 24-month period before mitomycin C application. After an endoscopic dilation, mitomycin C was applied onto the dilation wound using a rigid endoscope.
Results: No complications were observed after the procedure. One child required a second application of mitomycin C 2 weeks after the first application because of recurrence of dysphagia. All the children remained asymptomatic and none of them required further dilation over a mean follow-up period of 24 months. Radiological control examinations revealed that there was no recurrence of the esophageal strictures and esophageal biopsies performed during follow-up showed no signs of dysplasia.
Conclusions: Local application of mitomycin C is a potential alternative to iterative dilations, surgery, or stent placement for the treatment of refractory esophageal strictures in children. However, prospective, long-term assessment of outcomes is needed before any definitive conclusion can be drawn about the usefulness of mitomycin C in these patients.

References

L. Michaud, M.D.

Unité de Gastro-entérologie, Hépatologie et Nutrition · Clinique de Pédiatrie · Hôpital Jeanne de Flandre

59037 Lille · France

Fax: +33-3-20-44-59-63

Email: l-michaud@chru-lille.fr